An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62-Reference-Cited by-同舟云学术

An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62

Published:2020-08 Issue: Volume:327 Page:109168
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Chen Hao,Dai Da-Peng,Zhou Shan,Liu Jian,Wang Shuang-Hu,Wu Hua-Lan,Zhou Quan,Geng Pei-Wu,Chong Jia,Lü You,Cai Jian-Ping,Yang Jie-Fu

Funder

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference25 articles.

1. Pharmacogenetics of warfarin in a diverse patient population;Mak;J. Cardiovasc. Pharmacol. Therapeut.,2019

2. Clinical model for predicting warfarin sensitivity;Ma;Sci. Rep.,2019

3. Pharmacogenetic considerations of anticoagulant medication;Miklosz;J. Physiol. Pharmacol.,2018

4. Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy;Al-Eitan;Saudi Pharmaceut. J.,2019

5. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: a systematic review;Dorji;J. Clin. Pharm. Therapeut.,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro;Frontiers in Pharmacology;2023-05-23

2. Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects;Frontiers in Endocrinology;2023-03-15

3. Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population;Frontiers in Pharmacology;2022-12-13

4. Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population;Frontiers in Cardiovascular Medicine;2022-11-24

5. PharmVar GeneFocus: CYP2C9;Clinical Pharmacology & Therapeutics;2021-07-12